FDA Approves New Preventive Drug for Hereditary Angioedema (HAE)
People with hereditary angioedema (HAE), a rare genetic disorder, may experience episodes of debilitating, unpredictable, and potentially life-threatening swelling in the abdomen, larynx (voice box), face, and extremities. But there is a new, first-of-its-kind drug to prevent these attacks: The U.S. Food and Drug Administration (FDA) has approved Andembry (garadacimab), a once-monthly medicine injected under […]
